| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
123,030,000 |
| Market
Cap: |
18.80(B) |
| Last
Volume: |
862,728 |
Avg
Vol: |
722,453 |
| 52
Week Range: |
$143.31 - $211.65 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 824 |
| Guru Rank Value : 0.5 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
21,700 |
98,555 |
124,204 |
268,793 |
| Total Sell Value |
$3,224,546 |
$16,182,261 |
$20,937,886 |
$52,053,725 |
| Total People Sold |
1 |
8 |
9 |
10 |
| Total Sell Transactions |
1 |
13 |
19 |
36 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Novartis Pharma Ag |
10% Owner |
– – • |
2005-10-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,267,865 |
|
- |
|
| Barrett Peter |
Director |
– • • |
2005-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
189 |
189 |
|
- |
|
| Barrett Peter |
Director |
– • • |
2005-09-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(668,731) |
14,057 |
|
- |
|
| Atlas Venture Associates Vi, L.p. |
10% Owner |
– – • |
2005-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,337,462) |
802,480 |
|
- |
|
| Schimmel Paul |
Director |
– • – |
2005-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
74 |
238,088 |
|
- |
|
| Schimmel Paul |
Director |
– • – |
2005-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
121 |
238,014 |
|
- |
|
| Vincent James L |
Director |
– • – |
2005-07-12 |
4 |
A |
$7.02 |
$70,200 |
D/D |
10,000 |
10,000 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2005-05-27 |
4 |
B |
$6.00 |
$783,120 |
I/I |
130,520 |
155,367 |
1.5 |
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-02-02 |
4 |
S |
$7.41 |
$629,850 |
I/I |
(85,000) |
30,384 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-02-01 |
4 |
S |
$7.18 |
$287,200 |
I/I |
(40,000) |
31,652 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-31 |
4 |
S |
$7.00 |
$168,000 |
I/I |
(24,000) |
32,248 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-26 |
4 |
S |
$7.09 |
$141,800 |
I/I |
(20,000) |
32,606 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-25 |
4 |
S |
$7.16 |
$143,200 |
I/I |
(20,000) |
32,904 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-21 |
4 |
S |
$7.58 |
$172,816 |
I/I |
(22,799) |
33,202 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-20 |
4 |
S |
$7.63 |
$64,855 |
I/I |
(8,500) |
33,541 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-19 |
4 |
S |
$7.74 |
$387,000 |
I/I |
(50,000) |
33,668 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2005-01-18 |
4 |
S |
$8.48 |
$366,109 |
I/I |
(43,163) |
13,918 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-18 |
4 |
S |
$8.54 |
$93,940 |
I/I |
(11,000) |
34,414 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-14 |
4 |
S |
$8.77 |
$120,149 |
I/I |
(13,700) |
34,578 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2005-01-12 |
4 |
S |
$9.30 |
$46,500 |
I/I |
(5,000) |
14,263 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2005-01-11 |
4 |
S |
$9.85 |
$197,050 |
I/I |
(20,000) |
14,303 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2005-01-10 |
4 |
S |
$9.87 |
$739,950 |
I/I |
(75,000) |
14,463 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2005-01-06 |
4 |
S |
$8.70 |
$869,750 |
I/I |
(100,000) |
15,063 |
|
- |
|
| Spoon Alan G |
10% Owner |
– – • |
2005-01-06 |
4 |
S |
$8.30 |
$207,500 |
I/I |
(25,000) |
34,783 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2005-01-05 |
4 |
S |
$8.07 |
$806,680 |
I/I |
(100,000) |
15,863 |
|
- |
|
748 Records found
|
|
Page 28 of 30 |
|
|
3.48 (2.33%) 
